Viewing Study NCT00729612


Ignite Creation Date: 2025-12-26 @ 10:44 PM
Ignite Modification Date: 2025-12-26 @ 10:44 PM
Study NCT ID: NCT00729612
Status: COMPLETED
Last Update Posted: 2018-04-02
First Post: 2008-08-06
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Sponsor: Greg Otterson
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-08-14
Start Date Type: ACTUAL
Primary Completion Date: 2011-12-16
Primary Completion Date Type: ACTUAL
Completion Date: 2011-12-16
Completion Date Type: ACTUAL
First Submit Date: 2008-08-06
First Submit QC Date: None
Study First Post Date: 2008-08-07
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2016-04-28
Results First Submit QC Date: None
Results First Post Date: 2016-06-06
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-03-06
Last Update Post Date: 2018-04-02
Last Update Post Date Type: ACTUAL